Rennova Health, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q1 2012 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Rennova Health, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q1 2012 to Q4 2022.
  • Rennova Health, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $23.8M, a 3.84% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $23.8M +$880K +3.84% Dec 31, 2022 10-K 2023-04-17
Q4 2021 $22.9M -$5.06M -18.1% Dec 31, 2021 10-K 2023-04-17
Q4 2020 $28M +$5.87M +26.6% Dec 31, 2020 10-K 2022-04-15
Q4 2019 $22.1M -$247K -1.1% Dec 31, 2019 10-K 2021-04-15
Q4 2018 $22.3M +$15M +203% Dec 31, 2018 10-K 2020-06-29
Q4 2017 $7.38M -$6.27M -45.9% Dec 31, 2017 10-K 2019-10-21
Q4 2016 $13.7M +$5.74M +72.6% Dec 31, 2016 10-K 2018-04-24
Q4 2015 $7.91M +$7.91M Dec 31, 2015 10-K 2017-04-11
Q1 2015 $47.9M -$1.44M -2.93% Mar 31, 2015 10-K 2015-06-26
Q4 2014 $0 Dec 31, 2014 10-K/A 2016-05-17
Q1 2014 $49.3M +$1.2M +2.49% Mar 31, 2014 10-K 2015-06-26
Q1 2013 $48.1M +$4.79M +11.1% Mar 31, 2013 10-K 2014-06-09
Q1 2012 $43.3M Mar 31, 2012 10-K 2013-06-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.